FDA News and Decisions: Midyear Updates

Exclusive Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first half of 2025.

The first half of 2025 brought about numerous developments in dermatology, with key decisions from the FDA and a surge of activity across submissions, trial advancements, and regulatory actions driving the pipeline forward. To help you stay informed, we compiled an overview of FDA approvals and clearances, new filings, and other pivotal regulatory movements in the specialty from January through June.